Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production an NF-κB Pathway
Overview
Affiliations
Threonyl-tRNA synthetase (TRS) is an aminoacyl-tRNA synthetase that catalyzes the aminoacylation of tRNA by transferring threonine. In addition to an essential role in translation, TRS was extracellularly detected in autoimmune diseases and also exhibited pro-angiogenetic activity. TRS is reported to be secreted into the extracellular space when vascular endothelial cells encounter tumor necrosis factor-α. As T helper (Th) type 1 response and IFN-γ levels are associated with autoimmunity and angiogenesis, in this study, we investigated the effects of TRS on dendritic cell (DC) activation and CD4 T cell polarization. TRS-treated DCs exhibited up-regulated expression of activation-related cell-surface molecules, including CD40, CD80, CD86, and MHC class II. Treatment of DCs with TRS resulted in a significant increase of IL-12 production. TRS triggered nuclear translocation of the NF-κB p65 subunit along with the degradation of IκB proteins and the phosphorylation of MAPKs in DCs. Additionally, MAPK inhibitors markedly recovered the degradation of IκB proteins and the increased IL-12 production in TRS-treated DCs, suggesting the involvement of MAPKs as the upstream regulators of NF-κB in TRS-induced DC maturation and activation. Importantly, TRS-stimulated DCs significantly increased the populations of IFN-γCD4 T cells, and the levels of IFN-γ when co-cultured with CD4 T cells. The addition of a neutralizing anti-IL-12 mAb to the cell cultures of TRS-treated DCs and CD4 T cells resulted in decreased IFN-γ production, indicating that TRS-stimulated DCs may enhance the Th1 response through DC-derived IL-12. Injection of OT-II mice with OVA-pulsed, TRS-treated DCs also enhanced Ag-specific Th1 responses . Importantly, injection with TRS-treated DC exhibited increased populations of IFN-γ-CD4 and -CD8 T cells as well as secretion level of IFN-γ, resulting in viral clearance and increased survival periods in mice infected with influenza A virus (IAV), as the Th1 response is associated with the enhanced cellular immunity, including anti-viral activity. Taken together, these results indicate that TRS promotes the maturation and activation of DCs, DC-mediated Th1 responses, and anti-viral effect on IAV infection.
He X, Zhang J, Jiang W, Wu P, Liu Y, Ren H Anim Nutr. 2024; 19:339-354.
PMID: 39640553 PMC: 11617288. DOI: 10.1016/j.aninu.2024.08.001.
Simoes M, Paiva K, de Souza I, Mello V, Martins da Silva I, Souza P Pharmaceutics. 2024; 16(7).
PMID: 39065638 PMC: 11280393. DOI: 10.3390/pharmaceutics16070941.
The mARS complex: a critical mediator of immune regulation and homeostasis.
Amanya S, Oyewole-Said D, Ernste K, Bisht N, Murthy A, Vazquez-Perez J Front Immunol. 2024; 15:1423510.
PMID: 38975338 PMC: 11224427. DOI: 10.3389/fimmu.2024.1423510.
Beyond protein synthesis: non-translational functions of threonyl-tRNA synthetases.
Barai P, Chen J Biochem Soc Trans. 2024; 52(2):661-670.
PMID: 38477373 PMC: 11088916. DOI: 10.1042/BST20230506.
Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection.
Khan D, Fox P Biochem Soc Trans. 2023; 51(6):2127-2141.
PMID: 38108455 PMC: 10754286. DOI: 10.1042/BST20230527.